
Orixone S 1000mg/500mg Injection
Marketer
Otik Biotec
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Orixone S 1000mg/500mg Injection
Combiflox, a dual-action injectable formulation (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation and propagation. Administration should strictly adhere to a healthcare provider's guidance; consistent adherence to the prescribed regimen is crucial, even with symptom improvement, to ensure treatment efficacy. Premature cessation may compromise therapeutic outcomes. Potential side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) demand prompt medical assistance. Prior to initiating treatment, disclose all current medications and health conditions to your physician. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor may order tests to monitor treatment response.
Uses of Orixone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Orixone S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Orixone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orixone S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Orixone S 1000mg/500mg Injection works:
The injectable formulation Orixone S (1000mg Ceftriaxone/500mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam, by counteracting bacterial resistance enzymes, potentiates Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Orixone S 1000mg/500mg Injection's concurrent use with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Orixone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Orixone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Orixone S 1000mg/500mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Orixone S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, Orixone S 1000mg/500mg Injection requires careful administration and potential dosage modification. Medical advice is recommended. Dosage alterations for Orixone S 1000mg/500mg Injection are unnecessary in individuals exhibiting mild to moderate liver dysfunction.
What if you forget to take Orixone S 1000mg/500mg Injection :
Should you forget a scheduled dose of Orixone S 1000mg/500mg Injection, seek medical advice immediately.
Facts to Know About Orixone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
